| Literature DB >> 35711752 |
Peng Fei1, He Jing1, Yan Ma1, Gege Dong1, Yunhe Chang2, Zhaoxu Meng3, Shilong Jiang4, Qinggang Xie4, Shuzhen Li5, Xi Chen6, Weiwei Yang7.
Abstract
The purpose of this study was to investigate the prevalence of Cronobacter spp. in commercial powdered infant formula (PIF) from nine provinces in China from March 2018 to September 2020, and to reveal the genotype, biofilm-forming ability, and antibiotic susceptibility of these isolates. A total of 27 Cronobacter strains, consisting of 22 Cronobacter sakazakii strains, 3 Cronobacter malonaticus strains, 1 Cronobacter turicensis strain, and 1 Cronobacter dublinensis strain, were isolated from 3,600 commercial PIF samples with a prevalence rate of 0.75%. Compared with the other 8 provinces, PIF from Shaanxi province had a higher prevalence rate (1.25%) of Cronobacter spp. These isolates were divided into 14 sequence types (STs), and 6 Cronobacter serotypes. The main Cronobacter STs were ST4, ST1, and ST64, and the dominant Cronobacter serotype was C. sakazakii serotype O2. Approximately 88.89% of Cronobacter isolates had a strong ability (OD595 > 1) to form biofilms on tinplate, among which the strains with ST4 were more dominant. All isolates were susceptible to ampicillin-sulbactam, ceftriaxone, cefotaxime, sulfadiazine, sulfadoxine, trimethoprim-sulfamethoxazole, gentamicin, tetracycline, ciprofloxacin, and colistin, while 55.56 and 96.30% isolates were resistant to cephalothin and vancomycin, respectively. Taken together, our findings highlighted the contamination status and characterization of Cronobacter spp. in commercial PIF from nine provinces of China, and provided guidance for the effective prevention and control of this pathogen in the production of PIF.Entities:
Keywords: Cronobacter spp.; antibiotic susceptibility; biofilm formation; commercial powdered infant formula; genotype
Year: 2022 PMID: 35711752 PMCID: PMC9197194 DOI: 10.3389/fmicb.2022.900690
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 6.064
Prevalence of Cronobacter spp. in commercial PIF from nine provinces in China.
|
|
|
|
|
|
|---|---|---|---|---|
| C-HLJ1 | Heilongjiang | 400 | 1 | 0.25% |
| C-J-1, C-J-2 | Jilin | 400 | 2 | 0.50% |
| C-HB1, C-HB2 | Hebei | 400 | 2 | 0.50% |
| C-HN1, C-HN2, C-HN3 | Henan | 400 | 3 | 0.75% |
| C-S-1, C-S-2, C-S-3, C-S-4, C-S-5 | Shaanxi | 400 | 5 | 1.25% |
| C-G-1, C-G-2, C-G-3, C-G-4 | Guizhou | 400 | 4 | 1.00% |
| C-Y-1, C-Y-2, C-Y-3, C-Y-4 | Yunnan | 400 | 4 | 1.00% |
| C-X-1, C-X-2 | Xinjiang | 400 | 2 | 0.50% |
| C-F-1, C-F-2, C-F-3, C-F-4 | Fuzhou | 400 | 4 | 1.00% |
| Total | 3,600 | 27 | 0.75% | |
MLST and O-antigen serotyping of 27 Cronobacter isolates.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| C-HLJ1 |
| 3480 | 64 | 64 | CsO2 |
| C-J-1 |
| 3481 | 4 | 4 | CsO2 |
| C-J-2 |
| 3482 | 8 | 8 | CsO1 |
| C-HB1 |
| 3483 | 19 | 24 | Undetected |
| C-HB2 |
| 3484 | 4 | 4 | CsO2 |
| C-HN1 |
| 3485 | 1 | 1 | CsO1 |
| C-HN2 |
| 3486 | 17 | 17 | CsO2 |
| C-HN3 |
| 3487 | 64 | 64 | CsO2 |
| C-S-1 |
| 3488 | 4 | 4 | CsO2 |
| C-S-2 |
| 3489 | 21 | 21 | CsO1 |
| C-S-3 |
| 3490 | 1 | 1 | CsO1 |
| C-S-4 |
| 3491 | 258 | CmO2 | |
| C-S-5 |
| 3492 | 21 | 21 | CsO1 |
| C-G-1 |
| 3493 | 4 | 4 | CsO2 |
| C-G-2 |
| 3494 | 1 | 1 | CsO1 |
| C-G-3 |
| 3495 | 108 | 4 | CsO2 |
| C-G-4 |
| 3496 | 77 | CdO1 | |
| C-Y-1 |
| 3497 | 4 | 4 | CsO2 |
| C-Y-2 |
| 3498 | 12 | CsO4 | |
| C-Y-3 |
| 3499 | 1 | 1 | CsO1 |
| C-Y-4 |
| 3500 | 83 | 83 | CsO7 |
| C-X-1 |
| 3501 | 40 | CsO4 | |
| C-X-2 |
| 3502 | 64 | 64 | CsO2 |
| C-F-1 |
| 3503 | 4 | 4 | CsO2 |
| C-F-2 |
| 3504 | 258 | CmO2 | |
| C-F-3 |
| 3505 | 7 | 7 | CmO2 |
| C-F-4 |
| 3506 | 8 | 8 | CsO1 |
.
Figure 1Phylogenetic relationship of 27 Cronobacter isolates containing 14 STs. The UPGMA tree based on 7 loci was constructed using MEGA7.0, with 1,000 bootstrap replicates. The Cronobacter sakazakii ATCC 29544, C. sakazakii ATCC BAA-894, C. sakazakii ATCC 29004, C. sakazakii ATCC 12868, Cronobacter malonaticus CDC 105877, Cronobacter dublinensis LMG 23823, Cronobacter turicensis LMG 23827, Cronobacter universalis NCTC 9529, Cronobacter condimenti LMG 26250, and Cronobacter muytjensii ATCC 51329 were used as the reference strains. Detailed information about each strain is added, including ST, CC, OT, and group.
Figure 2Biofilm biomass formed by 27 Cronobacter isolates on tinplate. The OD value at wavelength of 595 nm was used to indicate the biofilm biomass. (A) Cronobacter isolates belonging to group I. (B) Cronobacter isolates belonging to group II, group III group IV, group V, and group VI, respectively.
Antibiotic susceptibility of 27 Cronobacter isolates.
|
|
| |||
|---|---|---|---|---|
|
|
|
| ||
| β-Lactams | Ampicillin | 22 (81.48) | 0 (0.00) | 5 (18.52) |
| Amoxicillin | 23 (85.19) | 1 (3.70) | 3 (11.11) | |
| Cephalothin | 2 (7.41) | 10 (37.04) | 15 (55.56) | |
| Ampicillin-sulbactam | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Ceftriaxone | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Cefotaxime | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Macrolides | Azithromycin | 25 (92.59) | 0 (0.00) | 2 (7.41) |
| Erythromycin | 24 (88.89) | 1 (3.70) | 2 (7.41) | |
| Sulfonamides | Sulfadiazine | 27 (100.00) | 0 (0.00) | 0 (0.00) |
| Sulfadoxine | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Trimethoprim-sulfamethoxazole | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Aminoglycosides | Streptomycin | 24 (88.89) | 2 (7.41) | 1 (3.70) |
| Gentamicin | 27 (100.00) | 0 (0.00) | 0 (0.00) | |
| Amphenicols | Chloramphenicol | 20 (74.07) | 5 (18.52) | 2 (7.41) |
| Tetracyclines | Tetracycline | 27 (100.00) | 0 (0.00) | 0 (0.00) |
| Oxytetracycline | 26 (96.30) | 0 (0.00) | 1 (3.70) | |
| Glycopeptide | Vancomycin | 1 (3.70) | 0 (0.00) | 26 (96.30) |
| Fluoroquinolones | Ciprofloxacin | 27 (100.00) | 0 (0.00) | 0 (0.00) |
| Pipemidic acid | 26 (96.30) | 0 (0.00) | 1 (3.70) | |
| Polypeptide | Colistin | 27 (100.00) | 0 (0.00) | 0 (0.00) |